ReviewTranslational andrology and urology2018
eHealth and mHealth in prostate cancer detection and active surveillance.
Review in Translational andrology and urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic Review of Commercially Available Mobile Phone Applications for Prostate Cancer Education.American journal of men's healthPooled it
- The Role of mHealth Applications in Uro-Oncology: A Systematic Review and Future Directions.Cancers · 2025Review
- A randomized controlled trial of mobile intervention using health support bubbles to prevent social frailty.NPJ digital medicine · 2025Article
- Developing and validating a content quality evaluation tool for cancer mobile applications.BMC cancer · 2024Article
- Article
- Mobile Health Apps for Breast Cancer: Content Analysis and Quality Assessment.JMIR mHealth and uHealth · 2023Article
- A novel mHealth App (RyPros) for prostate cancer management: an accessibility and acceptability study.Translational andrology and urology · 2021Article
- Barriers and facilitators to mobile health and active surveillance use among older adults with skin disease.Health expectations : an international journal of public participation in health care and health policy · 2021Article
- Mind Your Data: Privacy and Legal Matters in eHealth.JMIR formative research · 2021Article
- Prostate Cancer Risk Calculator Apps in a Taiwanese Population Cohort: Validation Study.Journal of medical Internet research · 2020Article
- Mobile Health in Urology: The Good, the Bad and the Ugly.Journal of clinical medicine · 2020Review
- A Mobile Health Intervention for Prostate Biopsy Patients Reduces Appointment Cancellations: Cohort Study.Journal of medical Internet research · 2019Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
eHealth and mobile health (mHealth) offer patients, healthcare providers, researchers, and policy makers new potential to improve wellness, practice prevention and reduce suffering from diseases. While the eHealth market is growing to an expected US $26 billion, its potential in the field of Urology is still underused. Research has shown that currently only 176 apps (of the 300,000 medical apps available) were found in the Apple App Store and Google Play Store, of which 20 were prostate cancer related. Three good examples of eHealth/mHealth applications are the Rotterdam Prostate Cancer Risk Calculator (RPCRC) website and app, the Prostate cancer Research International Active Surveillance (PRIAS) website and the Follow MyPSA app for men on active surveillance for prostate cancer: they are tools with a clear vision that offer true added value in daily clinical practice and which positively influence healthcare beyond borders. To increase the uptake of eHealth applications in the coming years, it is important to involve professionals in their design and development, and to guarantee the safety and privacy of its users and their data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.